Core News Facts on Surgical Robotics Industry
Intuitive Surgical (NASDAQ: ISRG) reported a revenue of $2.51 billion for Q3 2025, up 23% year-over-year, with a 13% increase in its installed base of da Vinci surgical systems. This market leader in robotic-assisted surgery also noted a substantial addressable market for approved procedures, estimated to be three times its current footprint.
Medtronic (NYSE: MDT) achieved a 100% surgical success rate in its recent clinical study for the Hugo robotic-assisted surgery system, significantly surpassing the 85% performance goal. In Q2 FY2026, the company generated $9 billion in revenue, marking a 6.6% annual growth. The Hugo system is now FDA-cleared for urologic procedures, expanding its market presence.
Teradyne (NASDAQ: TER) reported Q3 2025 revenues of $769 million, with its semiconductor test segment contributing $606 million. Its robotics division brought in $75 million, highlighting a growing focus on automation solutions across manufacturing and logistics sectors.
